Global proteomics market is anticipated to grow at a CAGR of 16.6% during the forecast period (2024–2031). The proteomics market is mainly driven by the identification of potential new drugs for the treatment of chronic diseases. Proteomics technologies play a crucial role in molecular diagnostics, drug discovery, and medicines. Technological advancements in proteomics such as enhanced sensitivity and resolution, high throughput analysis, and mass spectrometry-based imaging have promoted the development of the proteomics market. However, the high cost and data management challenges pose significant restraints to market growth.
Browse the full report description of “Proteomics Market Size, Share & Trends Analysis Report by Product and Services (Instrumentation Technology, Reagents, and Software and Services), and by Application (Clinical Diagnostics, Drug Discovery and Development, and Others) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/proteomics-market
Proteomics research spans from discovering new vaccines, drugs, and diagnostic targets to characterizing protein-based products, studying toxicology, and identifying surrogate markets of activity in clinical research to understand drug mechanisms thoroughly. This involves the use of various types of instruments, platforms, systems, software, and databases, which contributes to the high cost of protein analytics. Also, proteomics experiment requires expertise in sample preparation, data analysis, and interpretation. This expertise is costly to hire, especially for a smaller organization, and the high cost becomes a hindrance to market growth. Cost constraints can slow down market expansion.
The proteomics field is expanding rapidly, assisted by improvements in instrumentation accuracy, size, and affordability. This offers diverse opportunities for personalized and precision medicine, which could improve diagnosis, treatment, and disease management in the coming years. Addressing these challenges can be challenging for advancing proteomics research. Hence, it can be considered as one of the major challenges.
The North American region is likely to hold a notable share of the global proteomics market. Antibody-drug conjugates and protein therapies are important in the treatment and diagnostics of diseases in North America. In this region numerous modified therapeutic proteins have been approved for clinical use, hundreds of proteins are currently undergoing clinical trials for immunological disorders, cancer, infections, and age-related diseases, and several other conditions.
Recent Developments
Market Coverage
· The market number available for 2023-2031
· Base year: 2023
· Forecast period: 2024-2031
· Segment Covered-
o By Product
o By Application
· Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape: Agilent Technologies, Inc., Bruker Corp., Danaher Corp., Merck KGaA, and Thermo Fisher Scientific Inc. among others.
Key questions addressed by the report
Global Proteomics Market Report Segment
By Product
By Application
Global Proteomics Market Report Segment by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Italy
· Spain
· France
· Rest of Europe
Asia-Pacific
· China
· India
· Japan
· South Korea
· Rest of Asia-Pacific
Rest of the World
· Latin America
· The Middle East and Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/proteomics-market